Minireviews
Copyright ©The Author(s) 2015.
World J Hepatol. May 28, 2015; 7(9): 1251-1257
Published online May 28, 2015. doi: 10.4254/wjh.v7.i9.1251
Figure 1
Figure 1 Pathogenic mechanisms of valproic acid-induced nonalcoholic fatty liver disease/nonalcoholic steato-hepatitis. VPA: Valproic acid; GABA: Gamma-aminobutyric acid; FIAF: Fasting-induced adipose factor; ADIPO-R1: Adiponectin receptor expression; NAFLD: Nonalcoholic fatty liver disease; NASH: Nonalcoholic steato-hepatitis.